Shares of Moderna Inc.
MRNA,
+3.66%
advanced 3.66% to $133.02 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index
COMP,
+0.86%
rising 0.86% to 10,952.61 and the Dow Jones Industrial Average
DJIA,
+1.34%
rising 1.34% to 31,499.62. This was the stock’s second consecutive day of gains. Moderna Inc. closed $243.63 short of its 52-week high ($376.65), which the company achieved on November 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc.
ABBV,
+2.60%
rose 2.60% to $150.89, Amgen Inc.
AMGN,
+3.72%
rose 3.72% to $261.32, and AstraZeneca PLC ADR
AZN,
+0.38%
rose 0.38% to $55.18. Trading volume (4.1 M) remained 899,416 below its 50-day average volume of 5.0 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
